Skip to main navigation

Search for:

Live - Top Menu

Clinical Trials
Investors & Media
Careers
Contact Us

Main navigation

Our Focus
Our Research
Our Medicine
Our Story

Home > Investors & Media > Press Releases

Investors & Media

Shareholder Tools

Email Alerts
Download Library
RSS
Print
Share

Facebook
LinkedIn
Twitter

Press Releases

Press Releases

Items Per Page

Year

Jan 03, 2008

Intercept Pharmaceuticals Names Dr. Luciano Adorini Chief Scientific Officer

Read More

May 21, 2007

Intercept Pharmaceuticals Expands Senior Management

Company establishes New COO Position, Announces Chief Medical Officer and Vice President, Program Management

Read More

May 16, 2006

Intercept Pharmaceuticals Closes $41 Million Equity Financing

Company Announces Lead Compound INT-747 Appears Well Tolerated in Phase 1 Study

Read More

May 04, 2005

Intercept Pharmaceuticals Announces Closing Of New Financing Round

Company to Present at Rodman & Renshaw Global Healthcare Conference

Read More

Oct 26, 2004

Liver And Metabolic Disease Company Intercept Pharmaceuticals To Present At Rodman & Renshaw Healthcare Conference

Company Also to Present Two Studies at The Liver Meeting™ Supporting Rationale

Read More

Aug 12, 2004

Intercept Pharmaceuticals Announces Publication Of Study Demonstrating Its Lead Compound Can Reverse Liver Fibrosis

Read More

Pagination

First page
Previous page
…
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Current page 26

Investors & Media

Shareholder Tools

Email Alerts
Download Library
RSS
Print
Share

Facebook
LinkedIn
Twitter

Live - Footer Menu

Privacy Policy
Privacy Shield Policy
Corporate Compliance
Terms of Use
Contact Us
Cookie Preferences

10 Hudson Yards, 37th Floor|New York, NY 10001|T: 844-782-ICPT

© 2020 Intercept Pharmaceuticals, Inc.